BIOMAT Database Logo BIOMAT Database Logo

Anti-HIV antibody and drug combinations exhibit synergistic activity against drug-resistant HIV-1 strains. 2017

Qianqian Qi, and Qian Wang, and Weizao Chen, and Fei Yu, and Lanying Du, and Dimiter S Dimitrov, and Lu Lu, and Shibo Jiang
Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College, Fudan University, Shanghai, China; Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10065, USA.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Qianqian Qi, and Qian Wang, and Weizao Chen, and Fei Yu, and Lanying Du, and Dimiter S Dimitrov, and Lu Lu, and Shibo Jiang
Combinations of the first and next generations of human immunodeficiency virus (HIV) fusion inhibitors exhibit a highly potent synergistic effect against enfuvirtide- sensitive and -resistant HIV type 1 strains.
August 2009, Journal of virology,
Qianqian Qi, and Qian Wang, and Weizao Chen, and Fei Yu, and Lanying Du, and Dimiter S Dimitrov, and Lu Lu, and Shibo Jiang
Synergistic Activity of Colistin-Containing Combinations against Colistin-Resistant Enterobacteriaceae.
October 2018, Antimicrobial agents and chemotherapy,
Qianqian Qi, and Qian Wang, and Weizao Chen, and Fei Yu, and Lanying Du, and Dimiter S Dimitrov, and Lu Lu, and Shibo Jiang
[Synergistic combinations of antibiotics against Klebsiella strains].
October 1974, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
Qianqian Qi, and Qian Wang, and Weizao Chen, and Fei Yu, and Lanying Du, and Dimiter S Dimitrov, and Lu Lu, and Shibo Jiang
Synergistic antiviral activity against drug-resistant HIV-1 by naturally occurring dipeptide and A single-stranded oligonucleotide.
May 2023, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy,
Qianqian Qi, and Qian Wang, and Weizao Chen, and Fei Yu, and Lanying Du, and Dimiter S Dimitrov, and Lu Lu, and Shibo Jiang
Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus.
May 2017, Future microbiology,
Qianqian Qi, and Qian Wang, and Weizao Chen, and Fei Yu, and Lanying Du, and Dimiter S Dimitrov, and Lu Lu, and Shibo Jiang
Antimicrobial activity of cephalosporin-beta-lactamase inhibitor combinations against drug-susceptible and drug-resistant Pseudomonas aeruginosa strains.
June 2020, Journal of Taibah University Medical Sciences,
Qianqian Qi, and Qian Wang, and Weizao Chen, and Fei Yu, and Lanying Du, and Dimiter S Dimitrov, and Lu Lu, and Shibo Jiang
Florfenicol-Polyarginine Conjugates Exhibit Promising Antibacterial Activity Against Resistant Strains.
January 2022, Frontiers in chemistry,
Qianqian Qi, and Qian Wang, and Weizao Chen, and Fei Yu, and Lanying Du, and Dimiter S Dimitrov, and Lu Lu, and Shibo Jiang
Novel Synergistic Anti-Enteroviral Drug Combinations.
August 2022, Viruses,
Qianqian Qi, and Qian Wang, and Weizao Chen, and Fei Yu, and Lanying Du, and Dimiter S Dimitrov, and Lu Lu, and Shibo Jiang
Drug combinations as effective anti-leishmanials against drug resistant Leishmania mexicana.
August 2020, RSC medicinal chemistry,
Qianqian Qi, and Qian Wang, and Weizao Chen, and Fei Yu, and Lanying Du, and Dimiter S Dimitrov, and Lu Lu, and Shibo Jiang
Mangiferin, an anti-HIV-1 agent targeting protease and effective against resistant strains.
May 2011, Molecules (Basel, Switzerland),
Copied contents to your clipboard!